Beyond Air (NASDAQ:XAIR – Get Free Report) and Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends.
Risk & Volatility
Beyond Air has a beta of -0.18, meaning that its share price is 118% less volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent recommendations for Beyond Air and Alpha Tau Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Beyond Air | 0 | 1 | 3 | 1 | 3.00 |
| Alpha Tau Medical | 0 | 0 | 3 | 0 | 3.00 |
Profitability
This table compares Beyond Air and Alpha Tau Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Beyond Air | -3,272.46% | -240.15% | -109.38% |
| Alpha Tau Medical | N/A | -33.75% | -26.78% |
Earnings and Valuation
This table compares Beyond Air and Alpha Tau Medical”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Beyond Air | $1.16 million | 18.10 | -$60.24 million | ($1.64) | -0.27 |
| Alpha Tau Medical | N/A | N/A | -$29.16 million | ($0.40) | -5.70 |
Alpha Tau Medical has lower revenue, but higher earnings than Beyond Air. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
31.5% of Beyond Air shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 19.0% of Beyond Air shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Summary
Alpha Tau Medical beats Beyond Air on 7 of the 12 factors compared between the two stocks.
About Beyond Air
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
About Alpha Tau Medical
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.
